Articles

ESC Heart Valve Repair Hybrid OR Clinical trial/study

Cardiologists are restricting the use of transcatheter aortic valve implantation (TAVI) to very old or very sick patients at high surgical risk, according to research presented at the European...

Medtronic has reached two clinical program milestones for its CoreValve system in the United States. It completed enrollment in its study of high-risk patients in its CoreValve U.S. Pivotal...

August 13, 2012 — Providers are increasingly focused on using interventional labs in a hybrid operating room (OR)...

Interventional procedures are growing rapidly and becoming more specialized in diverse areas of care.  In the next decade, the number of people living in the United States who have heart...

Each year, I find it interesting that some “new” technology being introduced by a vendor is actually an old, recycled idea.  

Cath lab volumes have gone down in recent years for several reasons, but one of the biggest reasons might be market saturation. This is certainly the case in Chicago, where nearly every hospital...

With last year’s U.S. Food and Drug Administration approval of transcatheter aortic valve replacement (TAVR) and increasingly complex cath lab and hybrid operating room (OR) ...

June 14, 2012 — A U.S. Food and Drug Administration (FDA) advisory panel voted in favor of recommending expanding the indication for the Edwards Lifesciences Sapien...

Methodist DeBakey Heart and Vascular Center in Houston, Tex., has leveraged new imaging and interventional technologies to help contain and reduce costs, increase patient volume and revenues and...

The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major cardiology show this year for vendors to display their latest innovations. A...